Revises sections of the uniform controlled substances act to remove specific opioid dosage requirements and revise the uniform controlled substances act in accordance with current standards of professional practice.
Impact
By repealing certain sections related to pain treatment, specifically the Intractable Pain Treatment Act, H7923 facilitates the prescribing of controlled substances for therapeutic purposes in a manner that considers the unique medical circumstances of patients. This could potentially improve the quality of life for many individuals suffering from severe chronic pain, as healthcare providers may be more willing to prescribe necessary medication without the constraints of rigid dosage requirements. Notably, the bill emphasizes the documentation of patient conditions and the rationale behind any prescribed treatment, which serves to safeguard the interests of both patients and practitioners.
Summary
House Bill 7923 aims to amend the Uniform Controlled Substances Act by revising the specific requirements related to opioid prescriptions and treatment of intractable pain. The bill has been introduced to align with contemporary medical practices, particularly concerning the prescription of opioids for patients suffering from chronic or severe pain. One of the significant changes is the removal of explicit dosage limits associated with opioid prescriptions, allowing practitioners more flexibility in tailoring pain management plans according to their patients’ specific needs.
Contention
Despite its positive outlook, the bill has sparked debate among legislators and health advocates. Critics have raised concerns that loosening restrictions on opioid prescriptions might lead to increased misuse of medications, given the opioid crisis impacting many regions. They argue that while the bill aims to provide better care for those with intractable pain, it may inadvertently facilitate an environment where opioids are unnecessarily prescribed, resulting in potential dependency. Hence, the discussions surrounding HB 7923 underline the delicate balance between enhancing patient care and addressing the ongoing challenges posed by opioid misuse.
Revises sections of the uniform controlled substances act to remove specific opioid dosage requirements, revises the uniform controlled substances act in accordance with current standards of professional practice and would repeal chapter 37.4 of title 5.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a ninety-day (90) supply may be dispensed at any one time.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a sixty-day (60) supply may be dispensed at any one time.
Amends current law on controlled substances to permit psilocybin to be cultivated within a person's residence for personal use and contingent on the US FDA's program, mandate that RI department of health establish rules regulations.
Establishes a searchable database of healthcare professionals' complaint histories, accessible to employers. License holders can review and dispute inaccuracies, while maintaining current criminal background check requirements.
Standardizes successor appointment language for various boards and adds language providing that a quorum be a majority of appointed members and the language applies across several healthcare professional boards that currently lack this language.
Standardizes successor appointment language for various boards and adds language providing that a quorum be a majority of appointed members and the language applies across several healthcare professional boards that currently lack this language.
Controlled substances: other; sentencing guidelines for retail sale of products containing ephedrine or pseudoephedrine; modify. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4947'25
Criminal procedure: sentencing guidelines; sentencing guidelines for illicit use of xylazine; provide for. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m).
Criminal procedure: sentencing guidelines; sentencing guidelines for delivering, manufacturing, or possessing with intent to deliver certain controlled substances; amend. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4255'25
Criminal procedure: sentencing guidelines; sentencing guidelines for delivering, manufacturing, or possessing with intent to deliver heroin or fentanyl; amend. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: SB 0430'25
Criminal procedure: sentencing guidelines; sentencing guidelines for manufacturing, creating, delivering, or possessing with intent certain schedule 1 and 2 controlled substances; amend. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: SB 460'25